0001104659-20-076462.txt : 20200624 0001104659-20-076462.hdr.sgml : 20200624 20200624164831 ACCESSION NUMBER: 0001104659-20-076462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamill Laura CENTRAL INDEX KEY: 0001751804 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 20986114 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 a4.xml 4 X0306 4 2020-06-23 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001751804 Hamill Laura C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 1 0 0 0 Non-Employee Stock Option (right to buy) 48.67 2020-06-23 4 A 0 32000 0 A 2020-07-23 2030-06-23 Common stock 32000 32000 D Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. The stock options vest in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service on the board of directors of Y-mAbs Therapeutics, Inc., and are exercisable immediately upon vesting. /s/ Laura Hamill 2020-06-24